GlassScriptPhysician profile
Bhola Nath Roy
NPI 1154381119
$1,922.41
in general payments reported to CMS, 2019-2025
20 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $355 · 2021: $284 · 2022: $123 · 2023: $211 · 2024: $101 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $529.63 | 2019-2025 | Breztri, Airsupra |
| Amgen INC. | $233.45 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $213.38 | 2019-2023 | Verquvo, Steglujan, Steglatro |
| Novo Nordisk INC | $211.63 | 2019-2024 | Ozempic |
| Pfizer INC. | $193.66 | 2019-2024 | |
| Lilly USA, LLC | $95.08 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Abbott Laboratories | $78.60 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $47.42 | 2019-2020 | |
| Corcept Therapeutics | $40.90 | 2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $39.27 | 2021-2022 | |
| Philips North America LLC | $37.63 | 2019 | |
| Esperion Therapeutics, INC. | $33.46 | 2020-2021 | |
| Abbvie INC. | $29.72 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $28.05 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.16 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.05 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.24 | 2019 | |
| Exact Sciences Corporation | $18.02 | 2023 | Cologuard Collection Kit |
| Alfasigma USA, INC. | $17.06 | 2022 | |
| Orexo US, INC. | $17.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhola Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.